Liposomal daunorubicin (Daunoxome) as part of treatment for hodgkin disease during pregnancy (1998)
Source: Blood. Conference titles: Annual Meeting of the American Society of Hematology. Unidade: FM
Assunto: HEMATOLOGIA
ABNT
DULLEY, Frederico Luiz et al. Liposomal daunorubicin (Daunoxome) as part of treatment for hodgkin disease during pregnancy. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 26 ago. 2024. , 1998APA
Dulley, F. L., Saboya, R., Macedo, M. C. M. A., Pallotta-Filho, R. S., Silva, R. L., Jamra, M. A., & Chamone, D. de A. F. (1998). Liposomal daunorubicin (Daunoxome) as part of treatment for hodgkin disease during pregnancy. Blood. Philadelphia: Faculdade de Medicina, Universidade de São Paulo.NLM
Dulley FL, Saboya R, Macedo MCMA, Pallotta-Filho RS, Silva RL, Jamra MA, Chamone D de AF. Liposomal daunorubicin (Daunoxome) as part of treatment for hodgkin disease during pregnancy. Blood. 1998 ; 92( 10): 236b.[citado 2024 ago. 26 ]Vancouver
Dulley FL, Saboya R, Macedo MCMA, Pallotta-Filho RS, Silva RL, Jamra MA, Chamone D de AF. Liposomal daunorubicin (Daunoxome) as part of treatment for hodgkin disease during pregnancy. Blood. 1998 ; 92( 10): 236b.[citado 2024 ago. 26 ]